Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01221961 · ClinicalTrials.gov registry record
Masimo Radical-7 Monitor a Useful Adjuvant During Major Spine Surgery
A clinical trial, sponsored by Cedars-Sinai Medical Center.
- Terminated
- Registry status
- 62
- Enrollment target
NCT01221961: Clinical Trial study, sponsored by Cedars-Sinai Medical Center.
NCT01221961 is a clinical trial that was terminated before completion, run by Cedars-Sinai Medical Center. The registered enrollment target is 62 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01221961 was terminated before completion, sponsored by Cedars-Sinai Medical Center.
- TERMINATED
- Registry status
- 62 participants
- Enrollment target
Study Summary
This is a study designed to compare the agreement of hemoglobin (Hb) measurements, documented at specific time points (the time a blood sample was obtained by the standard clinical care after physician/nurse orders it and, during that same time, the Hb value recorded by the Masimo Radical-7 monitor); recorded several times throughout patient's major spine surgery procedure (depending on how many times the physician/nurse orders the Hb value to be tested), between the standard clinical practice {intermittent measure of Hb \[Cedar Sinai Medical Center (CSMC) Lab and outside lab) and Masimo radical-7 device (continuous, non-invasive Hb level measurements)\*.
Primary Outcome
During the time surgery last.
Interventions
- DEVICE Masimo Radical-7
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2010-10 |
| Est. Completion | 2013-04 |
Why NCT01221961 stopped before completion
NCT01221961 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 62 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Masimo Radical-7 is the first listed.
NCT01221961 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01221961 about?
NCT01221961 is a clinical study titled "Masimo Radical-7 Monitor a Useful Adjuvant During Major Spine Surgery". This is a study designed to compare the agreement of hemoglobin (Hb) measurements, documented at specific time points (the time a blood sample was obtained by the standard clinical care after physician/nurse orders it and, during that same time, the Hb value recorded by the Masimo Radical-7 monitor)...
What is the current status of trial NCT01221961?
This trial is currently terminated. The enrollment target is 62 participants. The study started on 2010-10. Estimated completion is 2013-04.
What interventions are being tested in trial NCT01221961?
The interventions under investigation include: Masimo Radical-7 (DEVICE).
Who is sponsoring clinical trial NCT01221961?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia